GOLDMAN SACHS GROUP INC - AADI BIOSCIENCE INC ownership

AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 77 filers reported holding AADI BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AADI BIOSCIENCE INC
ValueSharesWeighting
Q2 2023$172,471
-3.5%
25,215
+2.1%
0.00%
Q1 2023$178,799
-49.0%
24,696
-9.7%
0.00%
Q4 2022$350,759
-3.6%
27,339
+6.1%
0.00%
Q3 2022$364,000
-32.3%
25,776
-41.0%
0.00%
Q2 2022$538,000
-46.8%
43,662
-26.7%
0.00%
Q1 2022$1,011,00059,5470.00%
Other shareholders
AADI BIOSCIENCE INC shareholders Q4 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 26,666$182,39524.91%
Alerce Investment Management, L.P. 1,630,830$11,154,87714.51%
ACUTA CAPITAL PARTNERS, LLC 1,849,402$12,649,9108.57%
Decheng Capital Management III (Cayman), LLC 526,329$3,600,0901.13%
Knott David M Jr 261,000$1,7850.71%
Ghost Tree Capital, LLC 250,000$1,710,0000.56%
Affinity Asset Advisors, LLC 187,675$1,283,6970.45%
Vivo Capital, LLC 509,572$6,456,2770.45%
Avoro Capital Advisors LLC 2,849,402$19,489,9100.26%
Lion Point Capital, LP 82,423$563,7730.26%
View complete list of AADI BIOSCIENCE INC shareholders